Pharmaceuticals, Biotechnology and Life Sciences
IRVINE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company…
Infant Bacterial Therapeutics AB today announces that the Patent Offices of Brazil and Hong Kong have approved a patent of…
COVISTIX maintains its ability to detect the Omicron Variant, in addition to detecting SARS-CoV-2 and all of its major variants…
cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster shot durability emerge The Company…
SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its…
Castellum Announces Signing of LOI to Acquire $4 million government contractor Castellum, Inc. (OTC: ONOV) announces the signing of a…
To be Published in the International Journal of CardiologySEATTLE, Dec. 27, 2021 (GLOBE NEWSWIRE) — Faraday Pharmaceuticals, Inc., a muscle…
NEW ORLEANS and LONDON, Dec. 27, 2021 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a Company developing…
Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial Objective Response Rate (ORR) by Blinded Independent Central Review…
FLORHAM PARK, N.J., Dec. 27, 2021 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived…